- Home
- RGNX vs GPAT Comparison
RGNX vs GPAT Comparison
Compare RGNX & GPAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- GPAT
- Stock Information
- Founded
- RGNX 2008
- GPAT 2020
- Country
- RGNX United States
- GPAT United States
- Employees
- RGNX N/A
- GPAT N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- GPAT
- Sector
- RGNX Health Care
- GPAT
- Exchange
- RGNX Nasdaq
- GPAT NYSE
- Market Cap
- RGNX 356.7M
- GPAT 365.5M
- IPO Year
- RGNX 2015
- GPAT 2024
- Fundamental
- Price
- RGNX $7.27
- GPAT $10.29
- Analyst Decision
- RGNX Buy
- GPAT
- Analyst Count
- RGNX 12
- GPAT 0
- Target Price
- RGNX $33.36
- GPAT N/A
- AVG Volume (30 Days)
- RGNX 698.7K
- GPAT 6.2K
- Earning Date
- RGNX 02-28-2025
- GPAT 01-01-0001
- Dividend Yield
- RGNX N/A
- GPAT N/A
- EPS Growth
- RGNX N/A
- GPAT N/A
- EPS
- RGNX N/A
- GPAT 0.30
- Revenue
- RGNX $84,327,000.00
- GPAT N/A
- Revenue This Year
- RGNX $2.23
- GPAT N/A
- Revenue Next Year
- RGNX $250.77
- GPAT N/A
- P/E Ratio
- RGNX N/A
- GPAT $34.03
- Revenue Growth
- RGNX N/A
- GPAT N/A
- 52 Week Low
- RGNX $6.56
- GPAT $9.98
- 52 Week High
- RGNX $28.80
- GPAT $10.30
- Technical
- Relative Strength Index (RSI)
- RGNX 41.90
- GPAT N/A
- Support Level
- RGNX $6.92
- GPAT N/A
- Resistance Level
- RGNX $7.79
- GPAT N/A
- Average True Range (ATR)
- RGNX 0.44
- GPAT 0.00
- MACD
- RGNX -0.04
- GPAT 0.00
- Stochastic Oscillator
- RGNX 19.40
- GPAT 0.00
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.